Back to search

Boston University

Fecal microbiota transplants as adjunctive therapy for major depressive disorder

Abstract

dc:description.abstract

Major depressive disorder (MDD) is a prevalent mood disorder that affects 280 million people globally. Current treatments for depression, such as selective serotonin reuptake inhibitors or serotonin and norepinephrine reuptake inhibitors, may have unwelcome side effects or may not ameliorate symptoms in cases of refractory depression and, thus, warrant the need for new and effective treatments or adjuncts. Research in the last decade has further explored the pathophysiology of MDD and the potential role of the Gut Brain Axis in depressive symptoms. Those clinically diagnosed with depression have been found to have differing microbiome compositions than those of healthy patients. Some preliminary studies have found that transplanting stool samples from healthy subjects into those with a dysfunctional gut microbiome have resulted in reduced depressive symptoms.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Physician Assistant Program
Grantor
Boston University
Year dc:date.issued
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Trinh, Sabrina
Advisors dc:contributor.advisor
  • Reffel, Angela
  • Weinstein, John

Subjects

dc:subject × 1

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/51835

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Trinh, Sabrina. Fecal microbiota transplants as adjunctive therapy for major depressive disorder. masters thesis, Boston University, 2024. https://hdl.handle.net/2144/51835